Skip to main content
Clinical Trials/IRCT20180815040802N1
IRCT20180815040802N1
Recruiting
Phase 3

Comparison of the Therapeutic effect of Oral Contraceptives with and without Dopamine Agonist ( Cabergoline ) in Reducing the Size of Ovarian Benign Tumors

Tabriz University of Medical Sciences0 sites40 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Benign Ovarian Tumors.
Sponsor
Tabriz University of Medical Sciences
Enrollment
40
Status
Recruiting
Last Updated
7 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
7 years ago
Study Type
Interventional
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • All women with Benign Ovarian Tumors in Reproductive Age

Exclusion Criteria

  • Hyperprolactinemia
  • Hypercoagulability State
  • Valvular Heart Disease

Outcomes

Primary Outcomes

Not specified

Similar Trials